Hemogenyx Pharmaceuticals (HEMO) News Today GBX 1.32 -0.02 (-1.49%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Hemogenyx Pharmaceuticals PLC Announces Schedule for Phase I Clinical Trial OpeningOctober 30 at 8:02 PM | finance.yahoo.comHemogenyx Pharmaceuticals loss narrows amid reduced expensesSeptember 28, 2024 | lse.co.ukHemogenyx Pharmaceuticals Plc (HEMO.L) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC - FLT3 Assay Ready for Phase I Trials at MD AndersonSeptember 9, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CDX Development UpdateSeptember 3, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Presentation at CBD S&T ConferenceAugust 28, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Macrophage-Directed Therapies Summit PresentationJuly 29, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC HEMOMay 25, 2024 | morningstar.comHemogenyx Pharmaceuticals PLC (HEMO)May 20, 2024 | investing.comHemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023April 29, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Final ResultsApril 25, 2024 | finance.yahoo.comSMALL CAP IDEA: Why investors should add Hemogenyx Pharmaceuticals to their watchlistApril 15, 2024 | msn.comCompare with Oxurion NV (0G99)March 30, 2024 | msn.comHemogenyx Pharmaceuticals PLC Announces Total Voting RightsMarch 28, 2024 | finance.yahoo.comAlbo unveils ambitious $4 billion plan to overhaul remote housing in the Northern TerritoryMarch 13, 2024 | proactiveinvestors.comHemogenyx Pharmaceuticals discusses successful £3.5M capital raise as it advances HEMO-CAR-T programMarch 12, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Placing to Raise US$4.2 millionFebruary 29, 2024 | finance.yahoo.comLondon pre-open: Stocks to nudge up; HSBC in focusFebruary 21, 2024 | lse.co.ukLung Cancer Research Foundation and American Lung Cancer Screening Initiative Join Forces for "Plus One" CampaignFebruary 20, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals achieves breakthrough with HEMO-CAR-T program, CBR platformFebruary 20, 2024 | finance.yahoo.comHemogenyx shares rise on potential for CBR to treat brain diseasesFebruary 16, 2024 | lse.co.ukHemogenyx Pharmaceuticals PLC Announces CBR Brain DeliveryFebruary 16, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CBR Intranasal DeliveryFebruary 14, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces FDA Consents to Phase I Trials of HEMO-CAR-TFebruary 9, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces the Approval and Issuance of U.S. Conditioning PatentFebruary 2, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Submission of Complete Response to Clinical HoldJanuary 16, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals completes process qualification runJanuary 8, 2024 | lse.co.ukHemogenyx Pharmaceuticals PLC Announces Placing to Raise £534,375November 28, 2023 | finance.yahoo.comHemogenyx shares up as says CBR platform a potential cancer treatmentNovember 27, 2023 | lse.co.ukHemoGenyx Says CBR Platform Could Potentially Be Used for Cancer TreatmentNovember 27, 2023 | marketwatch.comHemogenyx Pharmaceuticals PLC Announces CBR Expanded to Treatment of CancerNovember 27, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Lentivirus Re-manufacturing CompletedNovember 15, 2023 | finance.yahoo.comEARNINGS: Dar Global profit multiplies, Hemogenyx loss widensSeptember 28, 2023 | lse.co.ukPrevail Partners to invest in Hemogenyx PharmaceuticalsSeptember 18, 2023 | seekingalpha.comHemogenyx Stock Rises on Premium Share SubscriptionSeptember 18, 2023 | marketwatch.comHemogenyx Pharmaceuticals Says FDA Accepted Plans to Address Leukemia Treatment ConcernsSeptember 14, 2023 | marketwatch.comHemogenyx Pharmaceuticals PLC - Clinical Hold Lift Plan is accepted by FDASeptember 14, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CBR Patent Application UpdateSeptember 8, 2023 | finance.yahoo.comIs Hemogenyx Pharmaceuticals (LON:HEMO) In A Good Position To Deliver On Growth Plans?August 28, 2023 | finance.yahoo.comHemogenyx says Hemo-Car-T treatment placed on clinical hold by US FDAJuly 10, 2023 | lse.co.ukHemogenyx Pharmaceuticals Addresses FDA Concern on Leukemia Treatment; Shares RiseJuly 10, 2023 | marketwatch.comHemogenyx Pharmaceuticals PLC Announces Full FDA Review for HEMO-CAR-T INDJuly 10, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Clinical Hold on IND for HEMO-CAR-TJune 2, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals Shares Fall After FDA Puts Leukemia Treatment Application on HoldJune 2, 2023 | marketwatch.comHemogenyx Pharmaceuticals PLC Announces Submission of IND for HEMO-CAR-TMay 9, 2023 | finance.yahoo.comNew York Pharmaceuticals NewsMay 6, 2023 | bizjournals.comHemogenyx Pharmaceuticals PLC Announces Final Results for the Year Ended 31 December 2022April 28, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Equity Incentive Pool Increase and Option GrantApril 28, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Analytical Release Tests CompletedMarch 23, 2023 | finance.yahoo.comWe're Not Very Worried About Hemogenyx Pharmaceuticals' (LON:HEMO) Cash Burn RateMarch 20, 2023 | finance.yahoo.com Get Hemogenyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HEMO and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here HEMO Media Mentions By Week HEMO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HEMO News Sentiment▼0.000.45▲Average Medical News Sentiment HEMO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HEMO Articles This Week▼10▲HEMO Articles Average Week Get Hemogenyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HEMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Redx Pharma News e-therapeutics News Poolbeg Pharma News C4X Discovery News Arecor Therapeutics News Sareum News Ondine Biomedical News Oncimmune News OptiBiotix Health News Synairgen News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HEMO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
